The introduction of nicotinamide as being a nicotine substitute in e-cigarette and smokeless items represents a significant regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist exercise and is thought to work as a sedative at significant dosages6. The promises m